In silico insight and mechanistic studies revealed that the anti-cystic effect of mebendazole in ADPKD is likely driven primarily by its inhibitory effect on microtubule polymerisation, with a potential contribution from the inhibition of protein kinase targets known or predicted to be involved in disease pathophysiology. Here, WEE1 is linked to autosomal dominant polycystic kidney disease.